Circular RNA (circRNA) Therapeutics & Technologies Market
完整報告名稱與涵蓋範圍
Circular RNA (circRNA) Therapeutics & Technologies Market Size, Share & Trends Analysis Report, By Offering (circRNA Therapeutic Candidates, Circularization Technologies and Platform Licensing, circRNA Synthesis Reagents and Manufacturing Services, circRNA Research and Diagnostic Tools), By Application (Protein Replacement and Rare Diseases, Oncology and In Vivo Cell Therapy, Vaccines and Infectious Diseases, Cardiometabolic and Other Chronic Diseases), By Development Stage (Preclinical, Phase 1 and Phase 2, Late-Stage and Commercial), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The circular RNA therapeutics and technologies market covers covalently closed RNA therapeutic candidates, the circularization technologies and platform licences that enable them, synthesis reagents and manufacturing services for circular constructs and research and diagnostic tools. Linear and self-amplifying RNA products are excluded. No circular RNA therapeutic is approved as of 2026, so forecast revenue is derived from clinical timelines, with near-term value in licensing, reagents and manufacturing.
Circular RNA lacks free ends and therefore resists exonuclease degradation, offering longer protein expression, reduced innate immune activation and freedom from capping chemistry, which has attracted investment from large pharmaceutical companies through acquisitions and alliances. Programs in development target in vivo CAR-T generation, protein replacement for rare and metabolic diseases, oncology and vaccines, and developers are refining ribozyme-, ligation- and enzyme-based circularization, internal ribosome entry site selection and purification of circular from linear species. Manufacturing scale-up, analytical methods to confirm circularity and intellectual property around circularization approaches are the main commercial considerations, and Chinese companies have become prominent in the field.
The United States and China lead development, with Europe contributing platform and manufacturing capabilities. Competition involves circular RNA specialists, pharmaceutical acquirers, mRNA leaders adding circular formats and reagent suppliers.
The InsightAce study delivers revenue forecasts in US$ across all offering, application, development stage and end user and regional segments for 2026-2035, alongside segment-level trend analysis, competitive landscape assessment and detailed company profiling.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Circular RNA (circRNA) Therapeutics & Technologies Market Snapshot
Chapter 4. Global Circular RNA (circRNA) Therapeutics & Technologies Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Offering Estimates & Trend Analysis
5.1. Offering & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Offering:
5.2.1. circRNA Therapeutic Candidates
5.2.2. Circularization Technologies and Platform Licensing
5.2.3. circRNA Synthesis Reagents and Manufacturing Services
5.2.4. circRNA Research and Diagnostic Tools
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. Application & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
6.2.1. Protein Replacement and Rare Diseases
6.2.2. Oncology and In Vivo Cell Therapy
6.2.3. Vaccines and Infectious Diseases
6.2.4. Cardiometabolic and Other Chronic Diseases
Chapter 7. Market Segmentation 3: By Development Stage Estimates & Trend Analysis
7.1. Development Stage & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Development Stage:
7.2.1. Preclinical
7.2.2. Phase 1 and Phase 2
7.2.3. Late-Stage and Commercial
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Biotechnology and Pharmaceutical Companies
8.2.2. Academic and Research Institutes
8.2.3. CDMOs
Chapter 9. Circular RNA (circRNA) Therapeutics & Technologies Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Orna Therapeutics (Eli Lilly and Company)
11.2. Sail Biomedicines
11.3. Circ Bio, Inc.
11.4. RiboX Therapeutics
11.5. Therorna Inc.
11.6. CirCode Biomed Co., Ltd.
11.7. BioNTech SE
11.8. Moderna, Inc.
11.9. Capstan Therapeutics (AbbVie Inc.)
11.10. Circio Holding ASA
11.11. Esperovax
11.12. Chimerna Therapeutics
11.13. Purecodon (Hangzhou) Biopharma
11.14. New England Biolabs, Inc.
11.15. Aldevron (Danaher)
圖表清單 List of Tables & Figures
Table 1. Global Circular RNA (circRNA) Therapeutics & Technologies Market Revenue Forecast by Offering, 2026-2035 (US$ Mn)
Figure 1. Global Circular RNA (circRNA) Therapeutics & Technologies Market Segmentation Overview
Table 2. Global Circular RNA (circRNA) Therapeutics & Technologies Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 2. Global Circular RNA (circRNA) Therapeutics & Technologies Market Share by Offering, 2026 & 2035
Table 3. Global Circular RNA (circRNA) Therapeutics & Technologies Market Revenue Forecast by Development Stage, 2026-2035 (US$ Mn)
Figure 3. Circularization Technology Landscape and Purification Challenges
Table 4. Global Circular RNA (circRNA) Therapeutics & Technologies Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Global Circular RNA (circRNA) Therapeutics & Technologies Market Share by Application, 2026 & 2035
Table 5. North America Circular RNA (circRNA) Therapeutics & Technologies Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. circRNA Clinical and Preclinical Pipeline by Application and Originating Region, 2026
Table 6. Europe Circular RNA (circRNA) Therapeutics & Technologies Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific Circular RNA (circRNA) Therapeutics & Technologies Growth Opportunity Analysis
Table 7. Asia Pacific Circular RNA (circRNA) Therapeutics & Technologies Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Expression Durability Comparison Across Linear, Self-Amplifying and Circular RNA Formats
Table 8. Latin America Circular RNA (circRNA) Therapeutics & Technologies Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Competitive Positioning of Key Circular RNA (circRNA) Therapeutics & Technologies Market Participants
Table 9. Middle East & Africa Circular RNA (circRNA) Therapeutics & Technologies Market Revenue by Country, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們